Program
ACADEMY
BOOK SIGNING
BREAK
INDUSTRY SUPPORTED SESSION
NETWORKING EVENT
PARALLEL SESSIONS
PLENARY SESSIONS
SHORT ORAL PRESENTATION ON E-POSTER SCREENS
WORKSHOP
ACADEMY
BOOK SIGNING
BREAK
INDUSTRY SUPPORTED SESSION
NETWORKING EVENT
PARALLEL SESSIONS
PLENARY SESSIONS
SHORT ORAL PRESENTATION ON E-POSTER SCREENS
WORKSHOP
| Time | Forum Hall | South Hall 2 A&B | Exhibition Area |
|---|---|---|---|
| 09:30-14:30 |
Academy of Autoimmunity
|
||
| 14:45-16:15 |
PLENARY 01: Real-World Autoantibodies: Diagnosis, Prognosis, And Therapeutic Implications
|
||
| 16:15-16:45 |
PLENARY 01 Continues: Challenge The Expert
|
||
| 16:45-17:00 |
Short Break
|
||
| 17:00-18:00 |
Opening Ceremony
|
||
| 18:00-19:00 |
Welcome Reception
|
||
| Time | Forum Hall | South Hall 2 A&B | North Hall | Exhibition Area | Station 01 | Station 02 | Station 03 | Station 04 | Station 05 | Station 06 | Station 07 | Station 08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08:00-09:30 |
PLENARY 02: Dilemmas In Sle And Aps
|
|||||||||||
| 09:30-10:00 |
PLENARY 02 Continues: Challenge The Expert
|
|||||||||||
| 10:00-10:30 |
Coffee Break, Exhibition, Poster Viewing
|
|||||||||||
| 10:05-10:25 |
New Book Signing Session 01: Autoimmune Disease Diagnosis
|
|||||||||||
| 10:30-12:00 |
PS01: SLE in Practice: From Treatment Response to Daily Care
|
PS02: Autoimmune Diseases: Experimental and Translational Aspects
|
PS03: EASI Session: Autoimmune serology in neuro-immunological diseases (PNS and IIM)
|
|||||||||
| 12:00-14:00 |
Lunch Break, Exhibition, Short Oral Discussion, E-Poster Viewing
|
|||||||||||
| 12:15-13:45 |
Industry Supported Session (Not Included In The Main Event Cme/Cpd Credit)
|
Industry Supported Session (Not Included In The Main Event Cme/Cpd Credit)
|
||||||||||
| 12:30-13:30 |
Short Oral Presentation 01: Systemic Lupus Erythematosus Meets Antiphospholipid Syndrome: From Pathogenesis to Treatment
|
Short Oral Presentation 02: ASIA (Autoimmune Syndrome Induced by Adjuvants) and Exposome: Environmental Triggers of Autoimmunity
|
Short Oral Presentation 03: Autoantibodies: From Diagnosis to Prognosis
|
Short Oral Presentation 04: Celiac Disease: Evolving Issues
|
Short Oral Presentation 05: COVID-19 and FIBROMYALGIA From Epidemiology to Therapeutics
|
Short Oral Presentation 06: Clinical Cases I
|
Short Oral Presentation 07: Myasthenia Gravis and Other Neurological Conditions
|
Short Oral Presentation 08: SLE: Pathogenesis Pearls
|
||||
| 14:00-15:30 |
PS04: Rheumatoid Arthritis—From Signatures to Strategies for Prevention
|
PS05: Clinical and Translational Aspects of Autoimmune and Autoinflammatory Diseases
|
PS06: Frontiers in Sjögren’s Disease and Rare Diseases
|
|||||||||
| 15:30-15:45 |
Short Break
|
|||||||||||
| 15:45-16:45 |
PS07: Vasculitis: Advances in Biomarkers, Etiologies, and Treatments
|
PS08: Debate and Emerging Clinical Aspects of Spondyloarthropathies
|
PS09: Diagnostic Breakthroughs
|
|||||||||
| 16:45-17:15 |
Coffee Break, Exhibition, Poster Viewing
|
|||||||||||
| 17:15-18:30 |
PS10: Evolving Concepts in Clinical and Laboratory Issues in Antiphospholipid Syndrome
|
PS11: Debate Is Seronegative Sjögren’s Syndrome a Distinct Clinical Entity?
|
PS12: Systemic Manifestations of Autoimmune Diseases
|
|||||||||
| Time | Forum Hall | South Hall 2 A&B | North Hall | Exhibition Area | Terrace 2A | Station 01 | Station 02 | Station 03 | Station 04 | Station 05 | Station 06 | Station 07 | Station 08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08:00-09:30 |
PLENARY 03: Novelties In Autoimmune Diseases
|
||||||||||||
| 09:30-10:00 |
PLENARY 03 Continues: Challenge The Expert
|
||||||||||||
| 10:00-10:30 |
Coffee Break, Exhibition, Poster Viewing
|
||||||||||||
| 10:05-10:25 |
New Book Signing Session 02
|
||||||||||||
| 10:30-12:00 |
PS13: Autoimmune Syndrome Induced by Adjuvants (ASIA): Expanding Horizons
|
PS14: Neuroimmunology in Focus: From Multiple Sclerosis to Neuropsychiatric Lupus
|
PS15: Exposome and Other Environmental Factors
|
||||||||||
| 10:30-12:30 |
WORKSHOP: Artificial intelligence (AI) In Autoimmunity: From Diagnosis To Treatment
|
||||||||||||
| 12:00-14:00 |
Lunch Break, Exhibition, Short Oral Discussion, E-Poster Viewing
|
||||||||||||
| 12:10-13:10 |
New Book Signing Session 03
|
||||||||||||
| 12:15-13:45 |
Industry Supported Session (Not Included In The Main Event Cme/Cpd Credit)
|
||||||||||||
| 12:30-13:30 |
Short Oral Presentation 09: Diagnostics and Novel Therapy
|
Short Oral Presentation 10: Dermatological Diseases: Emerging Insights
|
Short Oral Presentation 11: Pregnancy and Endocrine
|
Short Oral Presentation 12: Mechanisms of Autoimmunity
|
Short Oral Presentation 13: Microbiome and Miscellaneous
|
Short Oral Presentation 14: Autoantibodies: Clinical Insights
|
Short Oral Presentation 15: SLE: Clinical Cases
|
Short Oral Presentation 16: Endocrine Forefront of Thyroid and Diabetes
|
|||||
| 14:00-15:30 |
PS16: Autoimmune Aspects of Thyroid Diseases
|
PS17: Autoimmune Disease and Pregnancy
|
PS18: Integrating Diagnostics into Clinical Practice
|
||||||||||
| 14:00-16:00 |
Ultrasound WORKSHOP: Full-Immersion Musculoskeletal Ultrasound
|
||||||||||||
| 15:30-15:45 |
Short Break
|
||||||||||||
| 15:45-16:45 |
PS19: Autoantibodies: Markers or Makers of Autoimmunity?
|
PS20: Neuroimmunology in Focus
|
PS21A: Autoimmune Signals in the Nervous System: Autonomic Dysregulation and Anti-GPCR Antibodies
|
||||||||||
| 16:45-17:15 |
Coffee Break, Exhibition, Poster Viewing
|
||||||||||||
| 17:15-18:30 |
PS21B: Autoantibodies from Selected Abstracts
|
PS22: From Biomarkers to Breakthrough Therapies
|
PS23: Pediatric Autoimmunity
|
||||||||||
| Time | Forum Hall | South Hall 2 A&B | North Hall | Exhibition Area | Station 01 | Station 02 | Station 03 | Station 04 | Station 05 | Station 06 | Station 07 | Station 08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08:00-09:30 |
PLENARY 04: Frontiers in Etiology and Therapy in Autoimmune Diseases And MAI Awards
|
|||||||||||
| 09:30-10:00 |
PLENARY 04 Continues: Challenge The Expert
|
|||||||||||
| 10:00-10:30 |
Coffee Break, Exhibition, Poster Viewing
|
|||||||||||
| 10:30-12:00 |
PS24: Inflammation in Focus: Myositis, Vasculitis, and Shared Pathways
|
PS25: Cytokine Pathways and Therapeutic Targeting in Autoimmune Diseases
|
PS26: Infections + COVID-19, and Autoimmunity
|
|||||||||
| 12:00-14:00 |
Lunch Break, Exhibition, Short Oral Discussion, Poster Viewing
|
|||||||||||
| 12:15-13:45 |
Industry Supported Session (Not Included In The Main Event Cme/Cpd Credit)
|
|||||||||||
| 12:30-13:30 |
Short Oral Presentation 17: Rheumatoid Arthritis: Novel Frontiers
|
Short Oral Presentation 18: Systemic Sclerosis - Novelties
|
Short Oral Presentation 19: Multiple Sclerosis: New Aspects
|
Short Oral Presentation 20: From Sjögren to Spondyloarthropathy
|
Short Oral Presentation 21: Autoimmunity Miscellaneous
|
Short Oral Presentation 22: Myositis Autoantibodies
|
Short Oral Presentation 23: Rheumatoid Arthritis II
|
Short Oral Presentation 24: SLE: Clinical Aspects
|
||||
| 14:00-15:30 |
PS27: CAR-T + Novel Therapies
|
PS29: Lupus Nephritis
|
PS28: Fibromyalgia + Chronic Fatigue Syndrome, and Long COVID: From Pathophysiology to Therapy
|
|||||||||
| 15:30-15:45 |
Short Break
|
|||||||||||
| 15:45-16:45 |
PS30: Artificial Intelligence + ChatGPT
|
PS31: Diagnostic ii
|
PS32: Microbiome and Autoimmunity
|
|||||||||
| 16:45-17:15 |
Coffee Break, Exhibition, Poster Viewing
|
|||||||||||
| 17:15-18:30 |
PS33: Systemic Sclerosis
|
PS34: Cross-Organ Autoimmunity: From Gut to Liver and Beyond
|
PS35: ICAP Session
|
|||||||||